ID
33359
Beschreibung
Study ID: 106837 Clinical Study ID: HZA106837 Study Title: A Long-Term, Randomized, Double-Blind, Parallel Group Study of Fluticasone Furoate/GW642444 Inhalation Powder Once-Daily and Fluticasone Furoate Inhalation Powder Once-Daily in Subjects with Asthma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01086384 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone furoate/vilanterol Trade Name: Relvar Study Indication: Asthma
Stichworte
Versionen (2)
- 05.11.18 05.11.18 -
- 06.12.18 06.12.18 -
Rechteinhaber
GSK group of companies
Hochgeladen am
6. Dezember 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
A Parallel Group Study of Fluticasone Furoate/Vilanterol in Subjects with Asthma - 106837
Randomisation Criteria List
- StudyEvent: ODM
Beschreibung
If NO, please select all boxes corresponding to violations of any randomisation criteria
Alias
- UMLS CUI-1
- C0034656
- UMLS CUI-2
- C0243161
- UMLS CUI-3
- C1709750
Beschreibung
Inclusion
Alias
- UMLS CUI-1
- C1512693
Beschreibung
1. Evening pre-dose of FEV1 50% to 90% of the predicted normal
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0439565
- UMLS CUI [1,2]
- C0587117
- UMLS CUI [1,3]
- C0748133
- UMLS CUI [1,4]
- C0205307
Beschreibung
2. A documented use of albuterol/salbutamol and/or asthma symptoms on at least 3 of the last 7 consecutive days of the run-in period
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0001927
- UMLS CUI [1,2]
- C0004096
- UMLS CUI [1,3]
- C1457887
Beschreibung
Exclusion Criteria
Alias
- UMLS CUI-1
- C0680251
Beschreibung
1. Clinically significant abnormal laboratory tests during Visit 1, which are still abnormal upon repeat analysis and are not believed to be due to disease(s) present. Each investigator will use his/her discretion in determining the clinical significance of the abnormality. When in doubt, GSK, or designee should be notified so that a joint decision can be made.
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0438215
- UMLS CUI [1,2]
- C2826293
- UMLS CUI [1,3]
- C0545082
- UMLS CUI [2,1]
- C0008961
- UMLS CUI [2,2]
- C0022423
Beschreibung
2. Changes in asthma medication (excluding albuterol/salbutamol inhalation aerosol provided at Visit 1) occuring between Visits 1 and 2
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0004096
- UMLS CUI [1,3]
- C0392747
- UMLS CUI [2,1]
- C0001927
- UMLS CUI [2,2]
- C0205535
- UMLS CUI [2,3]
- C0001712
- UMLS CUI [3]
- C0545082
Beschreibung
3. Occurrence of a culture-documented or suspected bacterial or viral infection of the upper or lower respiratory tract, sinus or middle ear during the run-in period that led to a change in asthma management, or, in the opinion of the investigator, is expected to affect the subjects asthma status or the subjects ability to participate in the study
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C2745955
- UMLS CUI [1,2]
- C0004623
- UMLS CUI [2,1]
- C2745955
- UMLS CUI [2,2]
- C0042769
- UMLS CUI [3]
- C0041912
- UMLS CUI [4]
- C0149725
- UMLS CUI [5,1]
- C0008961
- UMLS CUI [5,2]
- C0871010
- UMLS CUI [6,1]
- C0004096
- UMLS CUI [6,2]
- C0449438
- UMLS CUI [7,1]
- C0085732
- UMLS CUI [7,2]
- C2348568
Beschreibung
If a subject experiences a severe asthma exacerbation during run-in , they may extend the run-in period to recover from the symptoms and wash-out any prohibited medications.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0349790
- UMLS CUI [2]
- C0019993
- UMLS CUI [3,1]
- C3840745
- UMLS CUI [3,2]
- C0545082
Beschreibung
5. Evidence of significant abnormality in the 12-lead ECG performed at Visit 1, as judged by the investigator. Selected specific ECG findings that are considered to be significant and will exclude the subject from study participation include, but are not limited to, the following:
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0430456
- UMLS CUI [1,2]
- C1704258
- UMLS CUI [2]
- C0545082
- UMLS CUI [3,1]
- C0008961
- UMLS CUI [3,2]
- C0022423
- UMLS CUI [4]
- C2348568
Ähnliche Modelle
Randomisation Criteria List
- StudyEvent: ODM
C0243161 (UMLS CUI-2)
C0243161 (UMLS CUI [1,2])
C0243161 (UMLS CUI-2)
C1709750 (UMLS CUI-3)
C0587117 (UMLS CUI [1,2])
C0748133 (UMLS CUI [1,3])
C0205307 (UMLS CUI [1,4])
C0004096 (UMLS CUI [1,2])
C1457887 (UMLS CUI [1,3])
C2826293 (UMLS CUI [1,2])
C0545082 (UMLS CUI [1,3])
C0008961 (UMLS CUI [2,1])
C0022423 (UMLS CUI [2,2])
C0004096 (UMLS CUI [1,2])
C0392747 (UMLS CUI [1,3])
C0001927 (UMLS CUI [2,1])
C0205535 (UMLS CUI [2,2])
C0001712 (UMLS CUI [2,3])
C0545082 (UMLS CUI [3])
C0004623 (UMLS CUI [1,2])
C2745955 (UMLS CUI [2,1])
C0042769 (UMLS CUI [2,2])
C0041912 (UMLS CUI [3])
C0149725 (UMLS CUI [4])
C0008961 (UMLS CUI [5,1])
C0871010 (UMLS CUI [5,2])
C0004096 (UMLS CUI [6,1])
C0449438 (UMLS CUI [6,2])
C0085732 (UMLS CUI [7,1])
C2348568 (UMLS CUI [7,2])
C0019993 (UMLS CUI [2])
C3840745 (UMLS CUI [3,1])
C0545082 (UMLS CUI [3,2])
C1704258 (UMLS CUI [1,2])
C0545082 (UMLS CUI [2])
C0008961 (UMLS CUI [3,1])
C0022423 (UMLS CUI [3,2])
C2348568 (UMLS CUI [4])